This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: University of California. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Lorenz Urner in Cancer Treatment
Introduction: Lorenz Urner is a distinguished inventor based in Los Angeles, California, known for his significant contributions to the field of cancer treatment. With one patent to his name, Urner has been actively involved in research aimed at improving therapeutic strategies against various forms of cancer, particularly those affecting the brain.
Latest Patents: Urner's notable patent focuses on "Compositions and methods for treating cancer." This patent discloses several compounds and methods intended for the effective treatment of cancer, including groundbreaking approaches that enable compounds to penetrate the blood-brain barrier. This is particularly vital for modulating the activity of EGFR tyrosine kinase, a critical target in cancers, such as glioblastoma and other EGFR-mediated malignancies. His work also emphasizes methods for treating cancers with altered glucose metabolism, showcasing a comprehensive approach to cancer therapies.
Career Highlights: Currently affiliated with the University of California, Urner’s research efforts have positioned him at the forefront of innovation in oncology. His expertise in developing cancer treatment methods illustrates the vital intersection of scientific research and practical application, with the potential to significantly enhance therapeutic outcomes for patients.
Collaborations: Throughout his career, Lorenz Urner has collaborated with esteemed professionals, including David A. Nathanson and Michael E. Jung. These partnerships have facilitated the exchange of ideas and the advancement of research, contributing to the development of cutting-edge cancer treatment methodologies.
Conclusion: Lorenz Urner stands out as a notable inventor in the realm of cancer research. His patent reveals a commitment to enhancing treatment options for patients battling formidable cancers, particularly through innovative strategies that address complex challenges. As research in this area progresses, Urner's contributions will likely serve as a foundation for future advancements in cancer therapy.